Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits
media
posted on 2021-06-07, 09:21 authored by Adis journals on behalf of, Mark G Lebwohl, Emil A Tanghetti, Linda Stein Gold, James Q Del Rosso, Nelly K Gilyadov, Abby Jacobson<p><strong>Article full
text</strong></p>
<p><br></p><p>
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.<b>
</b></p>
